References
- Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol 2012;8:650–8
- Klein RZ, Haddow JE, Faix JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991;35:41–6
- Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol 2011;54:478–87
- Breathnach FM, Donnelly J, Cooley SM, et al. Subclinical hypothyroidism as a risk factor for placental abruption: evidence from a low-risk primigravid population. Aust N Z J Obstet Gynaecol 2013;53:553–60
- Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081–125
- Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011;342:d2616
- Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 2012;97:777–84
- Practice Bulletin No. 148: thyroid disease in pregnancy. Obstet Gynecol 2015;125:996–1005
- Stagnaro-Green A. Screening pregnant women for overt thyroid disease. JAMA 2015;313:565–6
- De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012;97:2543–65
- Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760–5
- Parija SC, Raviprakash V, Telang AG, et al. Influence of hypothyroid state on 45Ca(2+) influx and sensitivity of rat uterus to nifedipine and diltiazem. Eur J Pharmacol 2001;421:207–13
- Parija SC, Mishra SK, Raviprakash V. Hypothyroid state reduces calcium channel function in 18-day pregnant rat uterus. Indian J Exp Biol 2006;44:19–27
- Wegener JW, Lee M, Hofmann F. Hypothyroidism does not affect the dihydropyridine sensitivity of precontracted murine uterus. Can J Physiol Pharmacol 2003;81:890–3
- Body mass index: considerations for practitioners. Available from: http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi
- Cohen WR, Hayes-Gill B. Influence of maternal body mass index on accuracy and reliability of external fetal monitoring techniques. Acta Obstet Gynecol Scand 2014;93:590–5
- Korevaar TIM, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 2013;98:4382–90
- Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ 2014;349:g4929
- Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009;94:21–5
- Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239–45
- Ashoor G, Maiz N, Rotas M, et al. Maternal thyroid function at 11–13 weeks of gestation and spontaneous preterm delivery. Obstet Gynecol 2011;117:293–8
- Karagiannis G, Ashoor G, Maiz N, et al. Maternal thyroid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates. Thyroid 2011;21:1127–31
- Tierney K, Delpachitra P, Grossmann M, et al. Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation. Clin Endocrinol (Oxf) 2009;71:892–5